Navigation Links
Revolutionary Pill Cuts Risk of Breast Cancer

The next five to ten years may see the development of a new contraceptive pill that reduces breast cancer risk as well as heart disease. It also has the added benefit of eliminating periods. //

The Combined Pill, currently available to women around the world is a combination of estrogen and progesterone. Estrogen however increases the risk of breast cancer and heart problems such as deep vein thrombosis.

Another, progesterone only drug, currently available in Britain also carries a risk of breast cancer mainly because of the progesterone in it.

The revolutionary new Pill uses a class of compounds known as the Progesterone Receptor Modulators (PRMs). These PRMs prevent the secretion of progesterone, which helps to maintain pregnancy.

As it neither contains estrogen nor progesterone but rather blocks the production of the latter, risks of breast cancer and heart problems are significantly reduced. Unlike the currently available drugs this new Pill also stops periods completely.

The new Pill could also herald an era of freedom from premenstrual symptoms and even endometriosis.

Professor David Baird, emeritus professor of reproductive endocrinology at the University of Edinburgh, has revealed that these PRMs were clinically tested on small groups of women with positive results and minimal side effects.

Teams in Sweden, Chile and the US have also worked on similar projects with the same compounds.

However experts warn that pro-life groups and the US Bush administration were hampering progress on the development of the new Pill as the new compound was developed on the basis of the RU486 abortion pill.

Pharmaceutical companies were also reluctant to market this drug for the very same reason.

Scientists claim that the development of this new Pill could bring transformations for millions of women. It would also reduce the risks of breast cancer and heart pr oblems, which accompany the currently available contraceptive pills.


'"/>




Related medicine news :

1. Revolutionary Simple Pregnancy Blood Test Can Save Both Mother And Child
2. A Revolutionary New Treatment For Cancer Available In Australia
3. New Revolutionary Drug Could Stop the Spread of HIV
4. Revolutionary New Treatment Plan Developed For Treatment Of Unexplained Symptoms
5. Revolutionary Net To Control Malaria
6. Revolutionary Net To Control Malaria
7. Revolutionary Eye Cancer Treatment
8. Revolutionary Pill Promises Relief for Hay Fever Sufferers
9. Consensus on "Combination Therapy" for Breast Cancer
10. Breast cancer treatment to be determined by gene test
11. Breast Feeding prevents obesity later on in life
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... Brooklyn, NY (PRWEB) , ... June 27, 2016 ... ... is using cutting edge technology to revolutionize the emergency ambulance transport experience for ... Many are aware of how Uber has disrupted the taxi industry through the ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet ... product that was developed to enhance the health of felines. The formula is all-natural ... two main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews ...
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology: